May 2025 $23 M Private placement after listing $10 to $50 million 1
VolitionRx Ltd.: Private sale, May 2025 × Investors in this round 1 investor had bought by the notice of Jan 28, 2026: 1 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $23 M of $23 M offered
Smallest investment taken no minimum stated
What was sold debt, options or other rights to buy securities, securities to be acquired by exercising them, other: Common Stock issuable upon conversion of Warrants and Senior Secured Convertible Promissory Notes Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Cameron Reynolds · Executive Officer, Director Gael Thomas Forterre · Executive Officer Gaetan Thomas Michel · Executive Officer Jacob Thomas Micallef · Executive Officer Jasmine Thomas Kway · Executive Officer Louise Batchelor · Executive Officer Nicholas Thomas Plummer · Executive Officer Rodney Rootsaert · Executive Officer Salvatore Thomas Butera · Executive Officer Terig Hughes · Executive Officer Alan Thomas Colman · Director Ethel I Rubin · Director Guy Archibald Innes · Director Kim Archibald Nguyen · Director Mickie Thomas Henshall · Director Phillip Archibald Barnes · Director Timothy I Still · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the amounts: “The Total Offering Amount consists of two separate closings including $6,400,000 in the additional closing held in January 2026 and assumes full exercise of the issued Warrants.”Signed by Cameron Reynolds, President and Chief Executive Officer. Source: SEC Form D, newest notice filed Jan 28, 2026. Read the notice at the SEC .
debt, options SEC Aug 2018 $24 M Private placement after listing $10 to $50 million 1
VolitionRx Ltd.: Private sale, Aug 2018 × Investors in this round 1 investor had bought by the notice of Aug 27, 2018: 1 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $24 M of $24 M offered
Smallest investment taken no minimum stated
What was sold equity, options or other rights to buy securities, other: Common Stock; Warrants Convertible into Common Stock Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Cameron Reynolds · Executive Officer, Director · President, Chief Executive Officer and Director David Cecil Vanston · Executive Officer · Chief Financial Officer Jacob Archibald Micallef · Executive Officer · Chief Scientific Officer Jason Archibald Terrell · Executive Officer · Chief Medical Officer Rodney Cecil Rootsaert · Executive Officer · Secretary Alan Archibald Colman · Director Edward Archibald Futcher · Director Guy Archibald Innes · Director Habib Archibald Skaff · Director Martin Charles Faulkes · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the amounts: “Includes $9,000,000 from sale of Common Stock and up to $15,000,000 from future conversion of Warrants into Common Stock”Signed by Cameron Reynolds, Chief Executive Officer. Source: SEC Form D, newest notice filed Aug 27, 2018. Read the notice at the SEC .
equity, options SEC Sep 2014 $1 M No. 3 Under $2 million 7
VolitionRx Ltd.: Raise no. 3, Sep 2014 × Investors in this round 7 investors had bought by the notice of Sep 25, 2014: 7 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $1 M of $1 M offered
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions $59,906
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Cameron Reynolds · Executive Officer, Director · President, Chief Executive Officer & Director Mike O'Connell · Executive Officer · Chief Financial Officer & Treasurer Rodney Gerard Rootsaert · Executive Officer · Secretary Alan Archibold Colman · Director Guy Archibold Innes · Director Habib Archibold Skaff · Director Martin Gerard Faulkes · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round "Founding Asset Management (""FAM"")" (CRD 122282) · London, United Kingdom Sold in NH Remarks in the notice On fees: “The $59,906 commission was calculated as 7% of the total investment from those certain investors introduced by FAM. Pursuant to a Settlement Agreement, the commission owed was converted into 27,230 shares of common stock.”Signed by Cameron Reynolds, President, Chief Executive Officer & Director. Source: SEC Form D, newest notice filed Sep 25, 2014. Read the notice at the SEC .
equity SEC Feb 2014 $3 M No. 2 $2 to $10 million 24
VolitionRx Ltd.: Raise no. 2, Feb 2014 × Investors in this round 24 investors had bought by the notice of Mar 11, 2014: 24 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $3 M of $3 M offered
Smallest investment taken no minimum stated
What was sold equity, options or other rights to buy securities Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees $160,000
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Cameron Reynolds · Executive Officer, Director Malcolm Lewin · Executive Officer Rodney Gerard Rootsaert · Executive Officer Alan Archibald Colman · Director Guy Archibald Innes · Director Martin Gerard Faulkes · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round Founding Asset Management (CRD 122282) · London, United Kingdom Sold in CT, WA Lake Street Capital Markets (CRD 164447) · Minneapolis, Minnesota Sold in CA, CO, CT, FL, IL, MA, MD, MN, MT, NC, NJ, NY, OH, PA, WA MZ Advisory Pte Ltd · Singapore, Singapore Sold in no state named, and outside the US Signed by Cameron Reynolds, Pres, ceo, director. Source: SEC Form D, newest notice filed Mar 11, 2014. Read the notice at the SEC .
equity, options SEC Apr 2012 $1 M No. 1 Under $2 million 33
VolitionRx Ltd.: Raise no. 1, Apr 2012 × Investors in this round 33 investors had bought by the notice of Jul 26, 2012: 33 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $1 M of $3 M offered; $2 M still to sell
Smallest investment taken no minimum stated
What was sold equity, options or other rights to buy securities
Meant to last a year or less
Issuer's revenue Up to $1 million
Sales commissions $52,483
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Cameron Reynolds · Executive Officer, Director · PRESIDENT, CEO, DIRECTOR Malcolm Lewin · Executive Officer · CFO, TREASURER Rodney Rootsaert · Executive Officer · SECRETARY Alan Colman · Director Guy Innes · Director Martin Faulkes · Director Satu Vainikka · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round ANDREWS SECURITIES LLC (CRD 36402) · Denver, Colorado Sold in CA, CO, FL, IL Signed by Cameron Reynolds, President, ceo, director. Source: SEC Form D, newest notice filed Jul 26, 2012. Read the notice at the SEC .
equity, options SEC Oct 2011 $2 M Issued in a merger or acquisition Under $2 million 38
VolitionRx Ltd.: Private sale, Oct 2011 × Investors in this round 38 investors had bought by the notice of Oct 28, 2011: 38 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $2 M of $2 M offered
Smallest investment taken no minimum stated
What was sold equity
Meant to last a year or less
Issuer's revenue No revenue
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Cameron Reynolds · Executive Officer, Director · President, Chief Executive Officer and Director Malcolm Lewin · Executive Officer · Chief Financial Officer and Treasurer Rodney Gerard Rootsaert · Executive Officer · Secretary Alan Archibald Colman · Director Guy Archibald Innes · Director Kevin John Alexander · Director Martin Gerard Faulkes · Director Satu Gerard Vainikka · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On a merger: “The offering is being made in connection with that certain Share Purchase Agreement dated September 26, 2011 which closed on October 6, 2011.”Signed by Cameron Reynolds, President, Chief Executive Officer and Director. Source: SEC Form D, newest notice filed Oct 28, 2011. Read the notice at the SEC .
equity SEC